Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treatment of Peyronie's Disease With Platelet-Rich Plasma
Sponsor: Herlev Hospital
Summary
The purpose of this pilot study is to optimize a planned randomized, double-blind, placebo-controlled clinical trial evaluating the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase. The pilot study aims to identify potential challenges in the practical execution of the clinical trial, particularly regarding PRP preparation and the blinding process. Furthermore, it seeks to evaluate the effects of PRP injections.
Official title: Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Pilot Study
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2025-03-10
Completion Date
2026-01-01
Last Updated
2025-08-13
Healthy Volunteers
No
Conditions
Interventions
Autologous Platelet Rich Plasma
10 mL PRP intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.
Saline solution
10 mL saline solution intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.
Locations (1)
Herlev and Gentofte University Hospital
Herlev, Denmark